Krystal Biotech Inc
KRYS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.92B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8.92 Billion |
|---|---|
| Enterprise Value | $8.46 Billion |
| Earnings per Share | $7.08 |
| Beta | 0.5 |
| Outstanding Shares | 29,610,000 |
Return
| Return on Equity | 15.68% |
|---|---|
| Return on Assets | 14.20% |
| Return on Invested Capital | 16.47% |
Valuation & Multiples
| P/E Ratio | 39.28 |
|---|---|
| PEG | -191.29 |
| Price to Sales | 20.06 |
| Price to Book Ratio | 6.27 |
| Enterprise Value to Revenue | 18 |
| Enterprise Value to EBIT | 35.59 |
| Enterprise Value to Net Income | 37 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 2, 2026
EPS Estimate
$1.79
Consensus analyst estimateRevenue Estimate
$125.77 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 16, 2027
EPS Estimate
$2.05
Consensus analyst estimateRevenue Estimate
$134.52 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 90.48% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.25%▼ 103.08% |
|---|---|
| Total Invested | $123.06M▼ 98.90% |
| Investors Holding | 117▼ 326.00% |